EUVIMEDEUVIMED entdecken
Leitlinie

EGFR Testing and the CAP/IASLC/AMP Lung Cancer Biomarker Testing Guidelines: Knowledge Gaps and Future Directions

Elena Vigliar, Umberto Malapelle, Claudio Bellevicine, Giancarlo Troncone

Lung Cancer Management · 01.04.2015 · 4 (2) · 87-95

DOI: 10.2217/lmt.15.4 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Lung Cancer Management, online erschienen am 18.03.2015. Verfasst von Elena Vigliar und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Vigliar, E., Malapelle, U., Bellevicine, C., & Troncone, G. (2015). EGFR Testing and the CAP/IASLC/AMP Lung Cancer Biomarker Testing Guidelines: Knowledge Gaps and Future Directions. Lung Cancer Management, 4(2), 87-95. https://doi.org/10.2217/lmt.15.4

Vancouver

Vigliar E, Malapelle U, Bellevicine C, Troncone G. EGFR Testing and the CAP/IASLC/AMP Lung Cancer Biomarker Testing Guidelines: Knowledge Gaps and Future Directions. Lung Cancer Management. 2015;4(2):87-95. doi:10.2217/lmt.15.4

BibTeX
@article{Vigliar2015,
  author = {Vigliar, Elena and Malapelle, Umberto and Bellevicine, Claudio and Troncone, Giancarlo},
  title = {EGFR Testing and the CAP/IASLC/AMP Lung Cancer Biomarker Testing Guidelines: Knowledge Gaps and Future Directions},
  journal = {Lung Cancer Management},
  year = {2015},
  volume = {4},
  number = {2},
  pages = {87--95},
  doi = {10.2217/lmt.15.4}
}
Kostenlos starten →